News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Opinion|Videos|February 14, 2025

A case of a mother experiencing PPD while on low-dose SSRI

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how a mother's persistent PPD symptoms despite SSRI treatment necessitated a comprehensive reevaluation of medication dosage, additional therapeutic interventions, and closer monitoring of treatment response to achieve better symptom control.

Episodes in this series

1 expert is featured in this series.

EP. 1 Overview of Postpartum Depression

1 expert is featured in this series.

EP. 2 Real-World Patient Perspective: Navigating Care for PPD

1 expert is featured in this series.

EP. 3 Real-World Patient Perspective: Breaking the Stigma of PPD and Seeking Support

1 expert is featured in this series.

EP. 4 Diagnostic Tools For PPD

1 expert is featured in this series.

EP. 5 Current and emerging treatments for PPD

1 expert is featured in this series.

EP. 6 A case of a mother experiencing PPD at 12 weeks postpartum

1 expert is featured in this series.

EP. 7 Treatment approach for a mother experiencing PPD at 12 weeks postpartum

1 expert is featured in this series.

EP. 8 A case of a mother experiencing PPD while on low-dose SSRI

1 expert is featured in this series.

EP. 9 Treatment approach for a mother experiencing PPD already on SSRI

postpartum depression

EP. 10 Panel Discusses Screening, Treatment, and Challenges for Postpartum Depression

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Concluding Thoughts: Practical Tips, Resources, and More

ByJonathan M. Meyer, MD, DLFAPA

December 8th 2025

postpartum depression

"Words Matter": Best Practices in Treating Postpartum Depression

ByErin Crown, MHS, PA-C, Psych-CAQ

December 1st 2025

A New Option: Getting TDM Data Faster

ByJonathan M. Meyer, MD, DLFAPA

December 1st 2025

Shulamit Bossewitch

The Emerging Field of Women's Mental Health: Nonpharmacologic Management of Postpartum Depression

November 25th 2025

postpartum depression

Providing Timely, Appropriate Treatment of Postpartum Depression

November 21st 2025

Latest CME

Real Psychiatry 2026

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Jersey City Psychiatry

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Southern Florida Psychiatry Conference

In-Person Event

Southern Florida Psychiatry Conference

December 4-5, 2026

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Trending on Psychiatric Times

FDA Approves First At-Home Brain Stimulation Device for Treatment of Depression

Trontinemab Shows Promise for Treatment of Alzheimer Disease in New Data at CTAD

NDA Submission: Olanzapine Extended-Release Injectable Suspension for Treatment of Schizophrenia

Alive at the End of the World

An Update on the Role of Valproate in Bipolar Disorder

© 2025 MJH Life Sciences^®

All rights reserved.